Affirm Results Presentation Deck

Transaction Costs Transaction Costs COVID Stress Applied to Allowance $148 12.0% FY Q3'20 affirm COVID Stress Released from Allowance Notes: 1. 2. 3. 4. 5. $46 3.8% FY Q4'20 $119 8.0% $109 5.3% $97 4.3% $114 4.6% FY Q1'21 FY Q2'21 FY Q3'21 FY Q4'21 $157 5.8% $177 4.0% $172 4.4% FY Q1'22 FY Q2'22 FY Q3'22 $65 5.3% FY Q3'20 $78 6.5% FY Q4'20 Transaction Costs ex-Provision $90 6.1% FY Q1'21 $97 $98 4.7% 4.3% $89 $94 3.6% 3.5% $125 $106 2.8% 2.7% FY Q2'21 FY Q3'21 FY Q4'21 FY Q1'22 FY Q2'22 FY Q3'22 Transaction Costs ($M) % of GMV Transaction Costs ex-Provision ($M) % of GMV In March 2020, we updated loss assumptions in our allowance for credit losses to reflect expected stress emerging from forecasted delinquencies and defaults. This resulted in an increase of the allowance for credit losses as a percent of loans held for investment from 8.9% as of February 29, 2020, to 14.6% as of March 31, 2020. In the months subsequent to this, we saw stronger than expected repayment history in the portfolio resulting in a release of the allowance. These applications or releases of stress on the allowance impact the income statement via the provision for credit losses operating expense line. Transaction Costs include Loss on loan purchase commitment, Provision for credit losses, Funding costs and Processing and servicing Transaction Costs ex-Provision include Loss on loan purchase commitment, Funding costs and Processing and servicing FY Q3'21 and FY Q4'21 amounts include adjustments to amounts previously reported due to understatements in certain prior period amounts related to the fair value measurement of contingent consideration and stock-based compensation. Metrics are unaudited 15

View entire presentation